These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 9681701

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC.
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [Abstract] [Full Text] [Related]

  • 47. Possible hemolytic uremic syndrome in three cats after renal transplantation and cyclosporine therapy.
    Aronson LR, Gregory C.
    Vet Surg; 1999; 28(3):135-40. PubMed ID: 10338157
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Gingival overgrowth among patients medicated with cyclosporin A and tacrolimus undergoing renal transplantation: a prospective study.
    Paixão CG, Sekiguchi RT, Saraiva L, Pannuti CM, Silva HT, Medina-Pestana J, Romito GA.
    J Periodontol; 2011 Feb; 82(2):251-8. PubMed ID: 20722530
    [Abstract] [Full Text] [Related]

  • 50. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.
    Kaufman DB, Kaplan B, Kanwar YS, Abecassis M, Stuart FP.
    Transplantation; 1995 Jun 27; 59(12):1737-9. PubMed ID: 7541579
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Cyclosporin or tacrolimus: which agent to choose?
    Danovitch GM.
    Nephrol Dial Transplant; 1997 Aug 27; 12(8):1566-8. PubMed ID: 9269630
    [No Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 54. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine.
    Okechuku G, Boulos AK, Herman L, Upadhyay K.
    Pediatr Transplant; 2015 May 27; 19(3):E78-82. PubMed ID: 25661468
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
    Jardine AG.
    Transpl Int; 2005 Apr 27; 18(4):379-84. PubMed ID: 15773954
    [Abstract] [Full Text] [Related]

  • 57. [Thrombotic microangiopathy after kidney transplantation].
    Basić-Jukić N, Jurić I, Brunetta-Gavranić B, Kes P, Bubić-Filipi L, Glavas-Boras S.
    Acta Med Croatica; 2008 Apr 27; 62 Suppl 1():93-6. PubMed ID: 18578340
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar 27; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 60. The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects.
    Jose M, Caring for Australians with Renal Impairment (CARI).
    Nephrology (Carlton); 2007 Feb 27; 12 Suppl 1():S66-74. PubMed ID: 17316284
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.